4.4 Article

Preliminary validation study of the Spanish version of the satisfaction with life scale in persons with multiple sclerosis

Journal

DISABILITY AND REHABILITATION
Volume 36, Issue 12, Pages 1001-1005

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.3109/09638288.2013.825650

Keywords

Life satisfaction; multiple sclerosis; reliability; subjective well-being; SWLS; validity

Categories

Funding

  1. European Commission [513723]

Ask authors/readers for more resources

Purpose: To assess Life Satisfaction, using the Satisfaction with Life Scale (SWLS), and to analyze its psychometric properties in Multiple Sclerosis (MS). Method: Persons with MS (n = 84) recruited at the MS Centre of Catalonia (Spain) completed a battery of subjective assessments including the SWLS, the World Health Organization Quality of Life instrument and disability module (WHOQOL-BREF, WHOQOL-DIS) and the Hospital Anxiety Depression Scale-Depression (HADS-D); sociodemographic and disability status data were also gathered. Psychometric properties of the SWLS were investigated using standard psychometric methods. Results: Internal consistency (Cronbach's alpha coefficient) was 0.84. A factor analysis using a principal components method showed a one factor structure accounting for 62.6% of the variance. Statistically significant correlations were confirmed between SWLS with WHOQOL-BREF, WHOQOL-DIS and HADS-D. SWLS scores were significantly different between a priori defined groups: probable depressed versus nondepressed and participants perceiving a mild versus severe impact of disability on their lives. Conclusion: To the best of our knowledge, this study is the first to report on the psychometrics properties of the SWLS in persons with MS. It might be a valuable tool to use in appraising persons with MS through the continuum of care.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease

Ruth Geraldes, Maciej Jurynczyk, Giordani Rodrigues dos Passos, Alexander Pichler, Karen Chung, Marloes Hagens, Serena Ruggieri, Cristina Auger, Jaume Sastre-Garriga, Christian Enzinger, Declan Chard, Frederik Barkhof, Claudio Gasperini, Alex Rovira, Gabriele DeLuca, Jacqueline Palace

Summary: The study found that peripheral pons lesion location is more common in MS cases, while it is almost non-existent in non-MS cases with VRF. The presence of peripheral pons lesions can effectively discriminate between MS and VRF-SVD.

MULTIPLE SCLEROSIS JOURNAL (2021)

Review Clinical Neurology

Mind the gap: from neurons to networks to outcomes in multiple sclerosis

Declan T. Chard, Adnan A. S. Alahmadi, Bertrand Audoin, Thalis Charalambous, Christian Enzinger, Hanneke E. Hulst, Maria A. Rocca, Alex Rovira, Jaume Sastre-Garriga, Menno M. Schoonheim, Betty Tijms, Carmen Tur, Claudia A. M. Gandini Wheeler-Kingshott, Alle Meije Wink, Olga Ciccarelli, Frederik Barkhof

Summary: MRI studies have provided important insights into the structure and function of neural networks in diseases like MS, where pathology affects brain networks and leads to clinical impairments. Understanding how MS pathology impacts brain networks can potentially inform new treatment approaches targeting neural network function.

NATURE REVIEWS NEUROLOGY (2021)

Article Clinical Neurology

Foveal changes in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressive

Adriana Roca-Fernandez, Frederike Cosima Oertel, Tianrong Yeo, Sedamirhosein Motamedi, Fay Probert, Matthew J. Craner, Jaume Sastre-Garriga, Hanna G. Zimmermann, Susanna Asseyer, Joseph Kuchling, Judith Bellmann-Strobl, Klemens Ruprecht, Maria Isabel Leite, Friedemann Paul, Alexander Ulrich Brandt, Jacqueline Palace

Summary: Foveal changes were observed in AQP4-Ab seropositive NMOSD patients, suggesting independent neuroaxonal damage from subclinical ON. The parafoveal area was altered in both ON and NON eyes compared to healthy controls, with discriminant analysis showing distinct foveal shape parameters between different groups. Further long-term follow-ups are needed to confirm the stability of the parafoveal structure over time.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Article Clinical Neurology

The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia

Luciana Midaglia, Jaume Sastre-Garriga, Agustin Pappolla, Laura Quibus, Rene Carvajal, Angela Vidal-Jordana, Georgina Arrambide, Jordi Rio, Manuel Comabella, Carlos Nos, Joaquin Castillo, Ingrid Galan, Breogan Rodriguez-Acevedo, Cristina Auger, Mar Tintore, Xavier Montalban, Alex Rovira

Summary: A low frequency of MS misdiagnosis was found in the clinical setting, with multifocal non-specific white matter lesions, comorbidities, and personal history of autoimmunity potentially contributing to misdiagnosis.

MULTIPLE SCLEROSIS JOURNAL (2021)

Article Clinical Neurology

Scoring the 10-year risk of ambulatory disability in multiple sclerosis: the RoAD score

Claudio Gasperini, Luca Prosperini, Alex Rovira, Mar Tintore, Jaume Sastre-Garriga, Carla Tortorella, Shalom Haggiag, Simonetta Galgani, Ruggero Capra, Carlo Pozzilli, Xavier Montalban, Jordi Rio

Summary: The study aimed to develop and validate a scoring system combining baseline prognostic factors and 1-year variables of treatment response to predict the long-term risk of disability accumulation in patients with RRMS. The RoAD score showed to be a useful tool in predicting the risk of reaching a disability milestone and optimizing treatment strategy for RRMS patients.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Article Clinical Neurology

CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event

Manuel Comabella, Margareta A. Clarke, Sabine Schaedelin, Mar Tintore, Deborah Pareto, Nicolas Fissolo, Rucsanda Pinteac, Cristina Granziera, Jaume Sastre-Garriga, Pascal Benkert, Cristina Auger, Jens Kuhle, Xavier Montalban, Alex Rovira

Summary: The presence of iron rims in patients with a first demyelinating event is associated with higher T2 lesion volume, a higher number of gadolinium-enhancing lesions, and increased levels of CSF CHI3L1 and serum NfL.

MULTIPLE SCLEROSIS JOURNAL (2022)

Article Clinical Neurology

Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis

Paola Valsasina, Claudio Gobbi, Chiara Zecca, Alex Rovira, Jaume Sastre-Garriga, Hugh Kearney, Marios Yiannakas, Lucy Matthews, Jacqueline Palace, Antonio Gallo, Alvino Bisecco, Achim Gass, Philipp Eisele, Massimo Filippi, Maria A. Rocca

Summary: This study evaluated the voxel-wise distribution and 1-year changes of cervical cord atrophy in a multicentre MS cohort, showing baseline and 1-year volume changes in different MS phenotypes. The results highlighted the correlation between baseline cord atrophy and disability, providing insights into spinal cord neurodegeneration over time in MS.

MULTIPLE SCLEROSIS JOURNAL (2022)

Article Clinical Neurology

SWI as an Alternative to Contrast-Enhanced Imaging to Detect Acute MS Lesions

G. Caruana, C. Auger, L. M. Pessini, W. Calderon, A. de Barros, A. Salerno, J. Sastre-Garriga, X. Montalban, A. Rovira

Summary: Qualitative analysis of signal patterns on SWI of new T2-hyperintense MS lesions allows determining the likelihood of enhancement, with high specificity. This method may be useful in some clinical settings where contrast agents cannot be administered.

AMERICAN JOURNAL OF NEURORADIOLOGY (2022)

Article Clinical Neurology

Serum neurofilament light chain levels predict long-term disability progression in patients with progressive multiple sclerosis

Manuel Comabella, Jaume Sastre-Garriga, Pere Carbonell-Mirabent, Nicolas Fissolo, Carmen Tur, Sunny Malhotra, Deborah Pareto, Francesc X. Aymerich, Jordi Rio, Alex Rovira, Mar Tintore, Xavier Montalban

Summary: This study found that serum neurofilament light chain (sNfL) levels can be used as a prognostic biomarker for future long-term disability progression in patients with progressive multiple sclerosis (MS).

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Article Clinical Neurology

Spinal cord reserve in multiple sclerosis

Jaume Sastre-Garriga, Alex Rovira, Aran Garcia-Vidal, Pere Carbonell-Mirabent, Manel Alberich, Angela Vidal-Jordana, Cristina Auger, Mar Tintore, Xavier Montalban, Deborah Pareto

Summary: This study aimed to test the existence of spinal cord (SC) reserve by using spinal canal area (SCaA) as a proxy. The results showed that a larger SCaA was significantly associated with lower scores on Patient Determined Disease Steps in multiple sclerosis (MS) patients, possibly supporting the existence of SC reserve.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Clinical Neurology

Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis

Alberto Calvi, Margareta A. Clarke, Ferran Prados, Declan Chard, Olga Ciccarelli, Manel Alberich, Deborah Pareto, Marta Rodriguez Barranco, Jaume Sastre-Garriga, Carmen Tur, Alex Rovira, Frederik Barkhof

Summary: This study found that chronic active lesions in magnetic resonance imaging (MRI), known as slowly expanding lesions (SELs) and paramagnetic rim lesions (PRLs), are associated with greater clinical progression in multiple sclerosis (MS) patients. SELs are more numerous than PRLs in MS patients.

MULTIPLE SCLEROSIS JOURNAL (2023)

Article Clinical Neurology

Validation of a New Semiautomated Segmentation Pipeline Based on the Spinal Cord Toolbox DeepSeg Algorithm to Estimate the Cervical Canal Area

N. Mongay-Ochoa, D. Pareto, M. Alberich, M. Tintore, X. Montalban, A. Rovira, J. Sastre-Garriga

Summary: A semiautomated pipeline was developed to obtain quantitative estimations of the cervical canal area and was found to be a reliable tool. Cervical canal area measurements remained consistent during a 1-year period, and estimations obtained from brain and cervical MRIs showed similar results.

AMERICAN JOURNAL OF NEURORADIOLOGY (2023)

Article Clinical Neurology

Assessing the Equivalence of Brain-Derived Measures from Two 3D T1-Weighted Acquisitions: One Covering the Brain and One Covering the Brain and Spinal Cord

D. Pareto, J. F. Corral, A. Garcia-Vidal, M. Alberich, C. Auger, J. Rio, N. Mongay, J. Sastre-Garriga, A. Rovira

Summary: The purpose of this study was to investigate the impact of replacing traditional brain T1-weighted images with an acquisition that included both the brain and the cervical spinal cord on brain and spinal cord measurements. The results showed that measurements obtained from cns-T1 were highly consistent with those obtained from brain-T1, suggesting the feasibility of using cns-T1 as a replacement.

AMERICAN JOURNAL OF NEURORADIOLOGY (2023)

Article Clinical Neurology

Prognostic value of single-subject grey matter networks in early multiple sclerosis

Vinzenz Fleischer, Gabriel Gonzalez-Escamilla, Deborah Pareto, Alex Rovira, Jaume Sastre-Garriga, Piotr Sowa, Einar A. Hogestol, Hanne F. Harbo, Barbara Bellenberg, Carsten Lukas, Serena Ruggieri, Claudio Gasperini, Tomas Uher, Manuela Vaneckova, Stefan Bittner, Ahmed E. Othman, Sara Collorone, Ahmed T. Toosy, Sven G. Meuth, Frauke Zipp, Frederik Barkhof, Olga Ciccarelli, Sergiu Groppa

Summary: This study investigated the prognostic value of longitudinal structural networks in predicting 5-year Expanded Disability Status Scale (EDSS) progression in relapsing-remitting multiple sclerosis (RRMS) patients. The study found that changes in network degree and global efficiency can predict disability accumulation independent of disease activity, and these network measures outperform conventional MRI predictors in predicting EDSS worsening.

BRAIN (2023)

Article Clinical Neurology

Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis

Nicolas Fissolo, Pascal Benkert, Jaume Sastre-Garriga, Neus Mongay-Ochoa, Andreu Vilaseca-Jolonch, Sara Llufriu, Yolanda Blanco, Harald Hegen, Klaus Berek, Francisco Perez-Miralles, Konrad Rejdak, Luisa M. Villar, Enric Monreal, Roberto Alvarez-Lafuente, Onder K. Soylu, Ahmed Abdelhak, Franziska Bachhuber, Hayrettin Tumani, Sergio Martinez-Yelamos, Antonio J. Sanchez-Lopez, Antonio Garcia-Merino, Lucia Gutierrez, Tamara Castillo-Trivino, Jan Lycke, Igal Rosenstein, Roberto Furlan, Massimo Filippi, Nieves Tellez, Lluis Ramio-Torrenta, Jan D. Lunemann, Heinz Wiendl, Sara Eichau, Michael Khalil, Jens Kuhle, Xavier Montalban, Manuel Comabella

Summary: This study aimed to investigate the potential of serum biomarker levels in predicting disability progression in patients with primary progressive multiple sclerosis (PPMS). The study found that levels of neurofilament light chain (sNfL), glial fibrillar acidic protein (sGFAP), and chitinase 3-like 1 (sCHI3L1) were associated with changes in the Expanded Disability Status Scale (EDSS) over different time periods.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

No Data Available